Balyasny Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $323K | Sell |
131,806
-221,151
| -63% | -$542K | ﹤0.01% | 1692 |
|
|
2025
Q1 | $2.35M | Buy |
+352,957
| New | +$2.35M | ﹤0.01% | 1112 |
|
|
2023
Q4 | – | Sell |
-34,205
| Closed | -$701K | – | 2205 |
|
|
2023
Q3 | $701K | Buy |
+34,205
| New | +$701K | ﹤0.01% | 1228 |
|
|
2023
Q1 | – | Sell |
-542
| Closed | -$10.6K | – | 2561 |
|
|
2022
Q4 | $10.6K | Sell |
542
-49,228
| -99% | -$963K | ﹤0.01% | 2111 |
|
|
2022
Q3 | $794K | Buy |
+49,770
| New | +$794K | ﹤0.01% | 1455 |
|
|
2017
Q1 | – | Sell |
-18,025
| Closed | -$440K | – | 1508 |
|
|
2016
Q4 | $440K | Buy |
18,025
+5,525
| +44% | +$135K | ﹤0.01% | 983 |
|
|
2016
Q3 | $474K | Buy |
+12,500
| New | +$474K | ﹤0.01% | 728 |
|